CAMP-8677 Switch Up

Switch UP to a Partner Built for What’s Next

What worked well at earlier stages doesn’t always translate as programs advance. As you move toward later-stage development, increasing demands around capacity, quality systems, regulatory readiness, and delivery reliability can introduce new complexities and require a partner equipped to support what’s next.

While switching can seem disruptive, remaining with a partner that cannot scale with your program often introduces greater long-term risk, from delays and added cost to increased operational and regulatory pressure. The question isn’t whether change is needed, but when and how to make it in a way that protects your progress.

Switching isn’t a setback. It’s a step UP with Aldevron.

Switching UP to Aldevron means partnering with a team built to support every stage of development with scalable manufacturing, proven regulatory readiness, dependable long-term stability, and flexible pricing that evolves with your program's growth.

Aldevron's Unmatched Difference

Scalability & Capability

Built to grow with your program, Aldevron's manufacturing platform supports you from research to clinical development and commercial production with capacity for every scale

Quality & Regulatory Confidence

With cGMP quality systems and a proven regulatory track record, Aldevron helps ensure your quality and comparability hold strong through each phase and transition

Delivery Reliability & Continuity

Consistent delivery performance and structured tech transfer processes help maintain continuity so your program moves forward without delays or disruption

Flexible Pricing

Tiered stage-aligned pricing allows you to invest at the right level today while scaling seamlessly as your program advances without overcommitting early

What our clients are saying

"Aldevron has been a reliable plasmid supply partner for our gene therapy program - collaborative, accommodating, and genuinely invested in the success of rare disease programs like ours. Their commitment to quality mirrors the rigor cell and gene therapy programs demand as they advance toward authorization."

Rarity PBC A Mission-Driven Biotechnology Company

"Aldevron’s team, particularly Beth, demonstrated exceptional dedication and problem-solving. Beth’s proactive communication and ability to secure an alternative carrier ensured our shipment arrived on time, preventing any disruption to our large animal surgery and research timelines. Their unwavering support has been instrumental in our success. Thank you, Beth and the Aldevron team!”

Cian O’Donnell Research Project Coordinator, University of Chicago